Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients

NCT00834301 is registered in ClinicalTrials.gov with Nephrian as lead sponsor.

NCT NCT00834301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00834301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients
Lead sponsor
Nephrian
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2009
Completion date
September 30, 2009
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperphosphatemia, inflammation, renal disease